九洲药业：公司已扎实推进系列市值管理举措

Core Viewpoint - Jiuzhou Pharmaceutical's stock performance is influenced by multiple factors including macroeconomic environment, industry policies, market conditions, and sector rotation [2] Group 1: Company Actions - The company is actively implementing a series of market value management measures to stabilize market expectations and convey long-term development confidence [2] - The share repurchase plan for 2025 is set to be completed, with the repurchase of treasury shares expected to be finalized in 2024 [2] - The company plans to successfully implement its semi-annual dividend plan for 2025 [2] Group 2: Future Outlook - The company aims to communicate its core value to the capital market based on stable operations [2] - The focus is on creating long-term and stable investment returns for shareholders [2]